{"id":"W4379283222","doi":"10.1200/jco.2023.41.16_suppl.tps2670","title":"A phase I/II dose escalation and expansion trial to evaluate safety and preliminary efficacy of BNT141 in patients with claudin-18.2-positive solid tumors.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Barrier Structure and Function Studies","field":"Neuroscience","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Gemcitabine; Tolerability; Radioimmunotherapy; Antibody; Internal medicine; Chemotherapy; Adverse effect; Immunology; Monoclonal antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001440544,0.001547031,0.001213912,0.0004753096,0.0003885551,0.0007990733,0.000786019,0.001381541,0.007240804],"category_scores_gemma":[0.0008272219,0.0004835623,0.0008994708,0.0003434072,0.0007872623,0.001012414,0.0004563368,0.003448026,0.001292224],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001143461,"about_ca_system_score_gemma":0.001246488,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007595301,"about_ca_topic_score_gemma":0.001945931,"domain_scores_codex":[0.999663,0.0001350376,0.00001424894,0.0000679837,0.00004075529,0.00007894171],"domain_scores_gemma":[0.9993352,0.00007474388,0.000147157,0.00005863146,0.00004491478,0.0003393155],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6909562,0.09266485,0.006025835,0.0009748908,0.0009683841,0.0003654478,0.0003762613,0.003571492,0.06745828,0.0007663698,0.01287686,0.1229951],"study_design_scores_gemma":[0.5893441,0.3900423,0.007181225,0.00004679333,0.0002567688,0.00040216,0.00007622606,0.00192698,0.004602861,0.0005270409,0.005562989,0.00003051158],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9854469,0.001638317,0.000921267,0.0009976464,0.0002367501,0.005087329,0.002317949,0.0001718014,0.003182003],"genre_scores_gemma":[0.9745076,0.001240572,0.003251369,0.001667219,0.0001594972,0.007912613,0.005293217,0.00006307321,0.005904985],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007240804,"threshold_uncertainty_score":0.02422291,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1110016579375653,"score_gpt":0.4566002010796958,"score_spread":0.3455985431421305,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}